1-15 of 981

Targeting Lipoprotein(a): A New Frontier in Heart Disease
Heart MattersTargeting Lipoprotein(a): A New Frontier in Heart Disease

The GRADE Framework: Five Lenses for Evaluating Randomized Trial Evidence
Heart MattersThe GRADE Framework: Five Lenses for Evaluating Randomized Trial Evidence

Treating What We Can: A Practical Approach to High Lipoprotein(a)
Heart MattersTreating What We Can: A Practical Approach to High Lipoprotein(a)

Turning an Lp(a) Result into a Prevention Opportunity
Heart MattersTurning an Lp(a) Result into a Prevention Opportunity

Rethinking CKD Screening in the Era of New Therapies
Heart MattersRethinking CKD Screening in the Era of New Therapies

Who Should Be Tested for Chronic Kidney Disease?
Heart MattersWho Should Be Tested for Chronic Kidney Disease?
- advertisement

Portopulmonary Hypertension: Signs, Symptoms, and Diagnosis
Clinician's RoundtablePortopulmonary Hypertension: Signs, Symptoms, and Diagnosis

Why Every Portopulmonary Hypertension Patient Needs a Liver Transplant Evaluation
Clinician's RoundtableWhy Every Portopulmonary Hypertension Patient Needs a Liver Transplant Evaluation

Screening for Significant Fibrosis in Patients with Obesity
GI InsightsScreening for Significant Fibrosis in Patients with Obesity

Obesity and Liver Disease: Getting to the Core of Treatment
GI InsightsObesity and Liver Disease: Getting to the Core of Treatment

Unmet Needs in PAH: Risk, Detection, and Treatment Burden
Clinician's RoundtableUnmet Needs in PAH: Risk, Detection, and Treatment Burden
- advertisement

Why PAH Centers of Excellence Are Important
Clinician's RoundtableWhy PAH Centers of Excellence Are Important

Spotting the Early Signs of Pulmonary Arterial Hypertension
Clinician's RoundtableSpotting the Early Signs of Pulmonary Arterial Hypertension




























